Latest news with #Phibro
Yahoo
5 days ago
- Business
- Yahoo
Phibro (PAHC) Up 7.4% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Phibro Animal Health (PAHC). Shares have added about 7.4% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Phibro due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. It turns out, fresh estimates have trended downward during the past month. Currently, Phibro has a great Growth Score of A, a grade with the same score on the momentum front. Following the exact same course, the stock was allocated a grade of A on the value side, putting it in the top 20% for this investment strategy. Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in. Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. Notably, Phibro has a Zacks Rank #1 (Strong Buy). We expect an above average return from the stock in the next few months. Phibro belongs to the Zacks Medical - Products industry. Another stock from the same industry, ResMed (RMD), has gained 2.7% over the past month. More than a month has passed since the company reported results for the quarter ended March 2025. ResMed reported revenues of $1.29 billion in the last reported quarter, representing a year-over-year change of +7.9%. EPS of $2.37 for the same period compares with $2.13 a year ago. ResMed is expected to post earnings of $2.47 per share for the current quarter, representing a year-over-year change of +18.8%. Over the last 30 days, the Zacks Consensus Estimate has changed -0.2%. ResMed has a Zacks Rank #3 (Hold) based on the overall direction and magnitude of estimate revisions. Additionally, the stock has a VGM Score of B. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Phibro Animal Health Corporation (PAHC) : Free Stock Analysis Report ResMed Inc. (RMD) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
23-04-2025
- Business
- Business Wire
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 7, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 8, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting The discussion will also be available by dialing +1 (888) 330-2022 in the U.S. and Canada, or +1 (365) 977-0051 for international callers. Provide the conference ID 3927884. A replay of the webcast will be available approximately two hours after the conclusion of the live event. To access the webcast recording, visit About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians, and consumers who raise or care for farm and companion animals by providing solutions to help them maintain and enhance the health of their animals. For further information, please visit Our filings with the Securities and Exchange Commission are available online at or on request from the company.
